Search research articles
Contact Us
Filters
Showing results (11-20 of 47) with videos related to
Page
of 5
Sort By:
Asia-Pacific Journal of Clinical Oncology
|
May 16, 2019
Phase II APEC trial: The impact of primary tumor side on outcomes of first-line cetuximab plus FOLFOX or FOLFIRI in patients with RAS wild-type metastatic colorectal cancer
Timothy Price, Lin Shen, Brigette Ma, et al.
Current Opinion in Immunology
|
May 26, 2023
Transcriptomics of Epstein-Barr virus aids to the classification of T-cell evasion in nasopharyngeal carcinoma
Shweta Mahajan, Michiel Bongaerts, Jose Hardillo, et al.
Clinical Colorectal Cancer
|
January 16, 2022
Total Neoadjuvant Therapy for High Risk Rectal Cancer in Western and Asian Populations - Current Evidence and Clinical Applications
David Johnson, Leung Li, Kin-Chung Lee, et al.
Asia-Pacific Journal of Clinical Oncology
|
October 26, 2024
Expert consensus on the optimal management of BRAF<sup>V600E</sup>-mutant metastatic colorectal cancer in the Asia-Pacific region
Oliver Piercey, Lorraine Chantrill, Hung-Chih Hsu, et al.
Asia-Pacific Journal of Clinical Oncology
|
January 27, 2021
Overcoming the impact of the COVID-19 pandemic on oncology early phase trials and drug development in Asia-Experiences and perspectives of the Asian Oncology Early Phase 1 Consortium
Toshio Shimizu, Dong-Wan Kim, Herbert H Loong, et al.
Cancer
|
July 23, 2003
Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type
Sing-fai Leung, Anthony T C Chan, Benny Zee, et al.
The Oncologist
|
February 19, 2016
Awareness, Understanding, and Adoption of Precision Medicine to Deliver Personalized Treatment for Patients With Cancer: A Multinational Survey Comparison of Physicians and Patients
Fortunato Ciardiello, Richard Adams, Josep Tabernero, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
December 17, 2024
Corrigendum to "Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities" [Transl. Res. 265 (2024) 1-16]
Deborah Lenoci, Carlo Resteghini, Mara S Serafini, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
November 10, 2023
Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities
Deborah Lenoci, Carlo Resteghini, Mara S Serafini, et al.
Targeted Oncology
|
February 18, 2021
BRAFV600E Mutations Arising from a Left-Side Primary in Metastatic Colorectal Cancer: Are They a Distinct Subset?
Vanessa Wong, Margaret Lee, Rachel Wong, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 47) with videos related to
Sort By:
Page
of 5
Asia-Pacific Journal of Clinical Oncology
|
May 16, 2019
Phase II APEC trial: The impact of primary tumor side on outcomes of first-line cetuximab plus FOLFOX or FOLFIRI in patients with RAS wild-type metastatic colorectal cancer
Timothy Price, Lin Shen, Brigette Ma, et al.
Current Opinion in Immunology
|
May 26, 2023
Transcriptomics of Epstein-Barr virus aids to the classification of T-cell evasion in nasopharyngeal carcinoma
Shweta Mahajan, Michiel Bongaerts, Jose Hardillo, et al.
Clinical Colorectal Cancer
|
January 16, 2022
Total Neoadjuvant Therapy for High Risk Rectal Cancer in Western and Asian Populations - Current Evidence and Clinical Applications
David Johnson, Leung Li, Kin-Chung Lee, et al.
Asia-Pacific Journal of Clinical Oncology
|
October 26, 2024
Expert consensus on the optimal management of BRAF<sup>V600E</sup>-mutant metastatic colorectal cancer in the Asia-Pacific region
Oliver Piercey, Lorraine Chantrill, Hung-Chih Hsu, et al.
Asia-Pacific Journal of Clinical Oncology
|
January 27, 2021
Overcoming the impact of the COVID-19 pandemic on oncology early phase trials and drug development in Asia-Experiences and perspectives of the Asian Oncology Early Phase 1 Consortium
Toshio Shimizu, Dong-Wan Kim, Herbert H Loong, et al.
Cancer
|
July 23, 2003
Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type
Sing-fai Leung, Anthony T C Chan, Benny Zee, et al.
The Oncologist
|
February 19, 2016
Awareness, Understanding, and Adoption of Precision Medicine to Deliver Personalized Treatment for Patients With Cancer: A Multinational Survey Comparison of Physicians and Patients
Fortunato Ciardiello, Richard Adams, Josep Tabernero, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
December 17, 2024
Corrigendum to "Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities" [Transl. Res. 265 (2024) 1-16]
Deborah Lenoci, Carlo Resteghini, Mara S Serafini, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
November 10, 2023
Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities
Deborah Lenoci, Carlo Resteghini, Mara S Serafini, et al.
Targeted Oncology
|
February 18, 2021
BRAFV600E Mutations Arising from a Left-Side Primary in Metastatic Colorectal Cancer: Are They a Distinct Subset?
Vanessa Wong, Margaret Lee, Rachel Wong, et al.
Page
of 5